CopyMark Law Group
4.9
Drawing for IMMUNOONE

USPTO serial 79361819

IMMUNOONE

Reviewed by CopyMark Law Group

Reg. 7204166Status 700Registered
Filing date
Status date
Registration date
Oct 31, 2023
Examiner
CANTONE, KERI H
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with IMMUNOONE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical, medical and veterinary preparations for the treatment of hyperproliferative and inflammatory diseases; pharmaceutical, medical and veterinary preparations comprising antibodies, antibody derivatives, and antigen binding fragments for the treatment of hyperproliferative and inflammatory diseasesACTIVE—
042Scientific and technological services and research, namely, scientific research, analysis and testing in the field of diseases using antibodies, antibody derivatives and antigen binding fragments; scientific and technological services and research in the nature of scientific research for the treatment and prevention of diseases using antibodies, antibody derivatives, and antigen binding fragments; analytical and research services; analytical scientific research and medical and scientific research services, namely, descriptive, diagnostic, predictive and prescriptive analytics for the treatment and prevention of disease using antibodies, antibody derivatives, and antigen binding fragments; pharmaceutical and biotechnological research and development; biotechnological research servicesACTIVE—
044Medical and veterinary services, namely, services for the treatment and prevention of diseases using antibodies, antibody derivatives, and antigen binding fragmentsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 21, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 27, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 6, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 6, 2024FIMPFINAL DISPOSITION PROCESSED—
Jan 31, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 31, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 31, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 15, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 15, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 26, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 11, 2023PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Jun 27, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 26, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Jun 26, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 26, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 26, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 15, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 14, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 14, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 31, 2023RFNTREFUSAL PROCESSED BY IB—
May 5, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 5, 2023RFRRREFUSAL PROCESSED BY MPU—
Mar 17, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 16, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 14, 2023DOCKASSIGNED TO EXAMINER—
Feb 10, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 6, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 3, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance